InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Thursday, 11/23/2017 9:08:09 PM

Thursday, November 23, 2017 9:08:09 PM

Post# of 48316
Oncosec's new CEO Dan O'Connor did this for ImClone and I believe he has ambitions to do the same for Oncosec.

(Nasdaq: IMCL) today announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5 billion.